Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Although genomic classifier tests for prostate cancer show promise, a systematic review of 22 studies reveals marked differences between observational and trial data in how these tests influence risk stratification and treatment selection.
Oncology, Medical February 3rd 2025
Journal of the Endocrine Society (JES)
Initial visit laboratory values, particularly HbA1C and 2-hour glucose, combined with BMI trajectory, offer more reliable predictive value for T2D progression than traditional fasting plasma glucose measurements.
Endocrinology, Diabetes, Metabolism January 30th 2025
Cleveland Clinic Journal of Medicine (CCJM)
Only 5% of Wernicke encephalopathy cases are diagnosed before death, yet the condition is fatal in 20% of untreated patients and leads to Korsakoff syndrome in over half of survivors.
Emergency Medicine December 4th 2024
MD Newsline
High-risk iFISH markers, such as CKS1B, IGH-FGFR3, and del17p, significantly affect survival outcomes in newly diagnosed multiple myeloma patients, with marked differences observed between high-risk and standard-risk cohorts.
Hematology/Oncology May 20th 2024
Renal & Urology News
Discover the key predictors of PSA persistence post-prostate cancer surgery and how they can inform your treatment plans and patient discussions.
Oncology, Medical October 2nd 2023